FR2812811B1 - Composition pharmaceutique contenant du citalopram - Google Patents

Composition pharmaceutique contenant du citalopram

Info

Publication number
FR2812811B1
FR2812811B1 FR0110586A FR0110586A FR2812811B1 FR 2812811 B1 FR2812811 B1 FR 2812811B1 FR 0110586 A FR0110586 A FR 0110586A FR 0110586 A FR0110586 A FR 0110586A FR 2812811 B1 FR2812811 B1 FR 2812811B1
Authority
FR
France
Prior art keywords
pharmaceutical composition
composition containing
containing citalopram
citalopram
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0110586A
Other languages
English (en)
French (fr)
Other versions
FR2812811A1 (fr
Inventor
Ken Liljegren
Per Holm
Ole Nielsen
Swen Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2812811(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of FR2812811A1 publication Critical patent/FR2812811A1/fr
Application granted granted Critical
Publication of FR2812811B1 publication Critical patent/FR2812811B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0110586A 2000-08-10 2001-08-08 Composition pharmaceutique contenant du citalopram Expired - Fee Related FR2812811B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27

Publications (2)

Publication Number Publication Date
FR2812811A1 FR2812811A1 (fr) 2002-02-15
FR2812811B1 true FR2812811B1 (fr) 2006-08-18

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0110586A Expired - Fee Related FR2812811B1 (fr) 2000-08-10 2001-08-08 Composition pharmaceutique contenant du citalopram

Country Status (34)

Country Link
EP (1) EP1318805A2 (ja)
JP (1) JP2003531153A (ja)
KR (1) KR20030024833A (ja)
CN (1) CN1446089A (ja)
AR (1) AR030095A1 (ja)
AT (1) AT5744U1 (ja)
AU (2) AU2001100198B4 (ja)
BE (1) BE1013559A6 (ja)
BG (1) BG107578A (ja)
BR (1) BR0113250A (ja)
CA (1) CA2353693C (ja)
CH (2) CH694241A5 (ja)
CZ (1) CZ2003397A3 (ja)
DE (2) DE10139115A1 (ja)
EA (1) EA200300247A1 (ja)
ES (1) ES2172481B2 (ja)
FI (1) FI5176U1 (ja)
FR (1) FR2812811B1 (ja)
GB (1) GB2368014B (ja)
GR (1) GR1004193B (ja)
HR (1) HRP20030054A2 (ja)
HU (1) HUP0103071A3 (ja)
IE (1) IES20010693A2 (ja)
IL (1) IL154050A0 (ja)
IS (1) IS6021A (ja)
IT (1) ITMI20011637A1 (ja)
MX (1) MXPA03000837A (ja)
NL (1) NL1018741C1 (ja)
NO (1) NO20013891L (ja)
NZ (1) NZ523785A (ja)
PL (1) PL359824A1 (ja)
SK (1) SK2842003A3 (ja)
WO (1) WO2001080619A2 (ja)
YU (1) YU9003A (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
PT1578738E (pt) * 2002-12-23 2008-04-11 Lundbeck & Co As H Bromidrato de escitalopram e um método para a sua preparação
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2480192A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
WO2017020841A1 (zh) * 2015-08-03 2017-02-09 深圳信立泰药业股份有限公司 一种含有lcz696的药物组合物及其制备方法
US20240100012A1 (en) * 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form
WO2024165628A1 (en) 2023-02-07 2024-08-15 Kinast Lasse An immediate-release oral pharmaceutical form of escitalopram or racemate thereof with increased api content

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram

Also Published As

Publication number Publication date
ES2172481B2 (es) 2004-08-01
GB2368014A (en) 2002-04-24
HUP0103071A3 (en) 2002-12-28
EA200300247A1 (ru) 2003-06-26
FR2812811A1 (fr) 2002-02-15
HRP20030054A2 (en) 2005-02-28
GR20010100377A (el) 2002-09-06
MXPA03000837A (es) 2003-06-06
NL1018741C1 (nl) 2002-02-12
JP2003531153A (ja) 2003-10-21
IES20010693A2 (en) 2002-07-10
CZ2003397A3 (cs) 2003-06-18
WO2001080619A2 (en) 2001-11-01
SK2842003A3 (en) 2003-09-11
DE20113195U1 (de) 2001-11-15
BG107578A (bg) 2003-09-30
HU0103071D0 (en) 2001-10-28
EP1318805A2 (en) 2003-06-18
KR20030024833A (ko) 2003-03-26
BE1013559A6 (fr) 2002-03-05
YU9003A (sh) 2006-05-25
FI5176U1 (fi) 2001-12-27
PL359824A1 (en) 2004-09-06
AU2001100198B4 (en) 2002-06-13
CN1446089A (zh) 2003-10-01
ITMI20011637A1 (it) 2003-01-27
BR0113250A (pt) 2003-06-24
GB2368014B (en) 2004-06-23
IL154050A0 (en) 2003-07-31
CA2353693C (en) 2003-07-22
CH694242A5 (de) 2004-10-15
AU2001100198A4 (en) 2001-08-16
IS6021A (is) 2001-10-20
ES2172481A1 (es) 2002-09-16
HUP0103071A2 (hu) 2002-05-29
CA2353693A1 (en) 2002-01-22
WO2001080619A3 (en) 2002-02-21
DE10139115A1 (de) 2002-03-28
ITMI20011637A0 (it) 2001-07-27
NO20013891L (no) 2002-02-11
CH694241A5 (de) 2004-10-15
AU2001279591A1 (en) 2001-11-07
GR1004193B (el) 2003-03-24
NO20013891D0 (no) 2001-08-09
AR030095A1 (es) 2003-08-13
AT5744U1 (de) 2002-11-25
NZ523785A (en) 2004-09-24
GB0118579D0 (en) 2001-09-19

Similar Documents

Publication Publication Date Title
MA26937A1 (fr) Nouvelle composition pharmaceutique.
NO20025450L (no) Ny farmasöytisk sammensetning
NO20030030L (no) Farmasöytiske blandinger av östrogene midler
MA27026A1 (fr) Composition pharmaceutique liquide
DK1052974T3 (da) Farmaceutisk sammensætning indeholdende epothilon
EE200200393A (et) Glüburiidi ravimkoostis
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
MA26865A1 (fr) Composition pharmaceutique parenterale contenant un biphosphonate
MA26968A1 (fr) Compositions pharmaceutiques contenant du maleate d'amlodipine.
IS6709A (is) Fljótandi samsetningar metformíns
ITMI20010748A0 (it) Composizioni farmaceutiche
PT1066027E (pt) Composicao farmaceutica de topiramato
FR2834890B1 (fr) Composition pharmaceutique orodispersible d'agomelatine
FR2812811B1 (fr) Composition pharmaceutique contenant du citalopram
DE69900561D1 (de) Pharmazeutische Zusammensetzungen enthaltend Mupirocin
DZ3155A1 (fr) Nouvelle composition pharmaceutique.
FR2817750B1 (fr) Composition pharmaceutique de dronedarone pour administration parenterale
FR2834896B1 (fr) Composition pharmaceutique orodispersible d'ivabradine
FR2752422B1 (fr) Composition pharmaceutique contenant des acides 4-oxo-butanoiques
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
NO20033073D0 (no) Farmasöytisk sammensetning inneholdende citalopram
EE200300138A (et) Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid
DK200100203U4 (da) Farmaceutisk komposition indeholdende citalopram
FR2790200B3 (fr) Formulation stable contenant de la fumagilline

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090430